REGENXBIO Inc. RGNX
$8.91
+10.61%
at last close
Financials (TTM)
- Revenue
- $174.48 million
- Net Income
- $-196,432,000
- Net Margin
- -112.58%
- Return on Equity
- -273.72%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 7.41
- Price / Sales
- 3.05
Over the trailing twelve months, REGENXBIO Inc. generated revenue of $174.48 million and net income of $-196,432,000, a net margin of -112.58%.
At the last closing price of $8.91, RGNX trades at 3.05 times sales, with a market capitalization of $531.74 million.
Key Stats
- Last Close
- $8.91
- Market Cap
- $531.74 million
- 52-Week Range
- $5.46 – $16.19
- Average Volume
- 1.58 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.